Importantly, we experimentally validated two C-to-U RESs, in CSNK2B (casein kinase II beta subunit) and RPS14 (ribosomal protein S14), respectively, with different impacts on cell proliferation in colon cancer. This evidence concerns the gene RPS14 and malignant colon neoplasm.